Finch Therapeutics Group, Inc.
FNCH
$13.25
-$0.20-1.49%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -24.72% | -27.46% | -25.87% | 65.24% | 88.85% |
| Total Depreciation and Amortization | 2.33% | -2.27% | -15.38% | -8.77% | -95.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.34% | 671.43% | -92.84% | 468.49% | -100.63% |
| Change in Net Operating Assets | 52.98% | -42.88% | 80.22% | -101.47% | -250.42% |
| Cash from Operations | -8.34% | -17.70% | 29.56% | 42.55% | 31.57% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | 85.00% | -98.43% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 155.00% | -98.43% | 9,171.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | 100.35% |
| Cash from Financing | -- | -- | -- | -100.00% | 100.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.34% | -19.34% | 30.26% | 33.52% | 73.33% |
